Granules India Ltd is in Breakout from a long term channel
Granules India Ltd and its subsidiaries are primarily involved in the manufacturing and selling of Active Pharma Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs) and Finished Dosages.
CMP: 694.15
PE: 34.2
Debt to equity: 0.41
Since the valuation is reasonable and lower than Industry PE is giving attraction to this stock.
The zone upto 697.5 is acting as LOP zone in lower time frame analysis.
Since the Pharma sector is in a trending upward flow, this stock can be a good pick with best fundamentals.
Few qty can buy above 698 and further above 721 level at closing basis.
CMP: 694.15
PE: 34.2
Debt to equity: 0.41
Since the valuation is reasonable and lower than Industry PE is giving attraction to this stock.
The zone upto 697.5 is acting as LOP zone in lower time frame analysis.
Since the Pharma sector is in a trending upward flow, this stock can be a good pick with best fundamentals.
Few qty can buy above 698 and further above 721 level at closing basis.
Disclaimer
The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.